Rep. Waxman leak unlikely to suppress off-label guidance
The chairman of the House Committee on Oversight and Government Reform provoked industry exponents last month by leaking FDA draft guidance on off-label journal reprints.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.